Key Points
- To review the physiological functions, voltage-gating mechanisms, and pharmacological modulators of Kv7 potassium channel subtypes in human disease.
- Literature review summarizing the discovery, cloning, and functional characterization of Kv7 channel subtypes in cardiac and nervous systems.
- Evaluation of synthetic channel openers and blockers developed to selectively regulate neuronal excitability.
- Four of the five identified Kv7 channel subtypes play direct, well-documented roles in human cardiac and neurological pathologies.
- Selective pharmacological modulation via subtype-specific openers and blockers effectively controls voltage gating and regulates neuronal excitability for therapeutic applications.
Structured PICO
IInterventionKv7 channel modulators (openers and blockers)
Provides a comprehensive overview of Kv7 channel physiology and the development of selective pharmacological modulators for therapeutic applications.